Eric L. Michelson

28.9k total citations · 14 hit papers
192 papers, 20.9k citations indexed

About

Eric L. Michelson is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Eric L. Michelson has authored 192 papers receiving a total of 20.9k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Cardiology and Cardiovascular Medicine, 19 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Surgery. Recurrent topics in Eric L. Michelson's work include Cardiac electrophysiology and arrhythmias (86 papers), Cardiac Arrhythmias and Treatments (58 papers) and Heart Failure Treatment and Management (44 papers). Eric L. Michelson is often cited by papers focused on Cardiac electrophysiology and arrhythmias (86 papers), Cardiac Arrhythmias and Treatments (58 papers) and Heart Failure Treatment and Management (44 papers). Eric L. Michelson collaborates with scholars based in United States, United Kingdom and Sweden. Eric L. Michelson's co-authors include John J.V. McMurray, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, Christopher B. Granger, Jan Östergren, Bertil Olofsson, Peter Held, Stuart Pocock and Scott D. Solomon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Eric L. Michelson

188 papers receiving 19.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

2003 2.0k citations Salim Yusuf, Marc A. Pfeffer et al. profile →
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

2003 1.8k citations John J.V. McMurray, Jan Östergren et al. profile →
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

2003 1.3k citations Marc A. Pfeffer, Karl Swedberg et al. profile →
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

2003 1.1k citations Christopher B. Granger, John J.V. McMurray et al. profile →
CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

2003 794 citations John J.V. McMurray, Jan Östergren et al. profile →
Predictors of mortality and morbidity in patients with chronic heart failure

2005 757 citations Stuart Pocock, Duolao Wang et al. profile →
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure

2007 752 citations G. Michael Felker, Larry A. Allen et al. Journal of the American College of Cardiology profile →
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

2006 733 citations Marc A. Pfeffer, Karl Swedberg et al. Circulation profile →
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

2006 619 citations Stevo Julius, Shawna D. Nesbitt et al. profile →
Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

2005 609 citations Scott D. Solomon, Nagesh S. Anavekar et al. Circulation profile →
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

2008 503 citations Mark C. Petrie, Jan Östergren et al. profile →
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.

1978 458 citations Eric L. Michelson et al. Circulation profile →
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

2007 457 citations Scott D. Solomon, Joanna Dobson et al. Circulation profile →
Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.

1978 428 citations Eric L. Michelson et al. Circulation profile →

Peers

Countries citing papers authored by Eric L. Michelson

Since Specialization

Citations

This map shows the geographic impact of Eric L. Michelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Michelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Michelson more than expected).

Fields of papers citing papers by Eric L. Michelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Michelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Michelson. The network helps show where Eric L. Michelson may publish in the future.

Co-authorship network of co-authors of Eric L. Michelson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Michelson. A scholar is included among the top collaborators of Eric L. Michelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Michelson. Eric L. Michelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corrigendum to ‘Analysing Recurrent Hospitalizations in Heart Failure: A Review of Statistical Methodology, with Application to CHARM-Preserved’ [ Eur J Heart Fail 2014;16:33–40] 2014 ·European Journal of Heart Failure ·Jennifer K. Rogers, Stuart Pocock, John J.V. McMurray, Christopher B. Granger, Eric L. Michelson, Jan Östergren, Marc A. Pfeffer, Scott D. Solomon, Karl Swedberg, Salim Yusuf	3
2	The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial 2011 ·Journal of the American College of Cardiology ·Benjamin M. Scirica, Christopher P. Cannon, Håkan Emanuelsson, Eric L. Michelson, Robert A. Harrington, Steen Husted, Stefan James, Hugo A. Katus, Prem Pais, Dimitar Raev, Jindřich Špinar, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin	92
3	Efficacy and Safety of Angiotensin Receptor Blockade are Not Modified by Aspirin in Patients with Chronic Heart Failure: A Cohort Study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) Programme 2010 ·European Journal of Heart Failure ·Su Min Chang, Christopher B. Granger, Peter A. Johansson, (unknown), John J.V. McMurray, Eric L. Michelson, David R. Murray, Bertil Olofsson, Marc A. Pfeffer, Scott D. Solomon, Karl Swedberg, Salim Yusuf, Mark E. Dunlap, (unknown)	10
4	Baseline Characteristics and Outcomes of Patients with Heart Failure Receiving Bronchodilators in the CHARM Programme 2010 ·European Journal of Heart Failure ·Nathaniel M. Hawkins, Duolao Wang, Mark C. Petrie, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Salim Yusuf, Scott D. Solomon, Jan Östergren, Eric L. Michelson, Stuart Pocock, Aldo P. Maggioni, John J.V. McMurray	55
5	Liver Function Abnormalities and Outcome in Patients with Chronic Heart Failure: Data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program 2009 ·European Journal of Heart Failure ·Larry A. Allen, G. Michael Felker, Stuart Pocock, John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, Duolao Wang, Salim Yusuf, Eric L. Michelson, Christopher B. Granger, (unknown)	296
6	Adherence to Medication According to Sex and Age in the CHARM Programme 2009 ·European Journal of Heart Failure ·Bradi B. Granger, Inger Ekman, Christopher B. Granger, Jan Östergren, Bertil Olofsson, Eric L. Michelson, John J.V. McMurray, Salim Yusuf, Marc A. Pfeffer, Karl Swedberg	108
7	Efficacy and Tolerability of Adding an Angiotensin Receptor Blocker in Patients with Heart Failure Already Receiving an Angiotensin-Converting Inhibitor Plus Aldosterone Antagonist, With or Without a Beta Blocker. Findings from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM)-Added Trial 2008 ·European Journal of Heart Failure ·Robin A.P. Weir, John J.V. McMurray, Margareta Puu, Scott D. Solomon, Bertil Olofsson, Christopher B. Granger, Salim Yusuf, Eric L. Michelson, Karl Swedberg, Marc A. Pfeffer, (unknown)	21
8	Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program 2008 ·Journal of the American College of Cardiology ·Peter Meredith, Jan Östergren, Inder S. Anand, Margareta Puu, Scott D. Solomon, Eric L. Michelson, Bertil Olofsson, Christopher B. Granger, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, John J.V. McMurray	33
9	TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension 2008 ·Journal of the American Society of Hypertension ·Stevo Julius, Niko Kaciroti, Brent M. Egan, Shawna D. Nesbitt, Eric L. Michelson	21
10	Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme 2007 ·European Journal of Heart Failure ·Nathaniel M. Hawkins, Duolao Wang, John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Salim Yusuf, Stuart Pocock, Jan Östergren, Eric L. Michelson, Francis G. Dunn	45
11	Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure breakdown → 2007 ·Circulation ·Scott D. Solomon, Joanna Dobson, Stuart Pocock, Hicham Skali, John J.V. McMurray, Christopher B. Granger, Salim Yusuf, Karl Swedberg, James B. Young, Eric L. Michelson, Marc A. Pfeffer	457
12	Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM 2006 ·European Journal of Heart Failure ·Eldrin F. Lewis, Gervasio A. Lamas, Eileen O’Meara, Christopher B. Granger, Mark E. Dunlap, Robert S. McKelvie, Jeffrey L. Probstfield, James B. Young, Eric L. Michelson, Katarina Halling, Jonas Carlsson, Bertil Olofsson, John J.V. McMurray, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, (unknown)	179
13	Patient Perception of the Effect of Treatment with Candesartan in Heart Failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme 2005 ·European Journal of Heart Failure ·Eileen O’Meara, Eldrin F. Lewis, C. B. Granger, Mark E. Dunlap, Robert S. McKelvie, Jeffrey L. Probstfield, James B. Young, Eric L. Michelson, Jan Östergren, Jonas Carlsson, Bertil Olofsson, John J.V. McMurray, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer	21
14	1069-113 Cause of death across full spectrum of ventricular function in patients with heart failure: The CHARM study 2004 ·Journal of the American College of Cardiology ·Scott D. Solomon, Bertil Olofsson, Peter Finn, Hicham Skali, Leonardo Antônio Mamede Zornoff, Satish Kenchaiah, Nagesh S. Anavekar, Jan Östergren, Eric L. Michelson, (unknown), (unknown), Salim Yusuf, John J.V. McMurray, C. B. Granger, Marc A. Pfeffer	2
15	Dilevalol compared with propranolol and placebo for systemic hypertension 1989 ·The American Journal of Cardiology ·James A. Schoenberger, William H. Frishman, John D. Wallin, (unknown), Michael Davidov, Eric L. Michelson, (unknown), (unknown), Marcia Poland	8
16	Nicardipine and hydrochlorothiazide in essential hypertension 1989 ·Clinical Pharmacology & Therapeutics ·Timothy C. Fagan, R Brown, Harold W. Schnaper, (unknown), (unknown), Eric L. Michelson, Kenneth A. Conrad, Jan Lessem, Donna Freedman	5
17	Combination propranolol and bepridil therapy in stable angina pectoris 1985 ·The American Journal of Cardiology ·William H. Frishman, Shlomo Charlap, D.John Farnham, Henry S. Sawin, Eric L. Michelson, Michael H. Crawford, Robert DiBianco, John B. Kostis, Stephen R. Zellner, David D. Michie, Richard J. Katz, Syed M. Mohiuddin, Udho Thadani	22
18	Evaluation of arrhythmogenicity of surgically induced endocardial versus ischemic myocardial damage 1984 ·Journal of Thoracic and Cardiovascular Surgery ·Lewis Wetstein, Eric L. Michelson, E. Neil Moore, Alden H. Harken	4
19	Supernormal response and conduction in depressed isolated canine ventricular muscle exposed to high potassium concentration 1983 ·Journal of the American College of Cardiology ·Hiroyuki Iinuma, Leonard S. Dreifus, (unknown), Eric L. Michelson	4
20	Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias 1983 ·Journal of the American College of Cardiology ·Joseph F. Spear, Eric L. Michelson, E. Neil Moore	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact